BioStar Ventures has collected over $68 million for its third fund. BioStar III will focus on backing “promising” medical technologies.Continue
King of Prussia, Pennsylvania-based Trice Medical, a private diagnostics company focused on micro invasive technologies, has appointed Craig Carra as its chief financial officer. Previously, Carra worked at Ella Health where he served as the financial and business development leader. Trice Medical is backed by HealthQuest Capital, Safeguard Scientifics and BioStar Ventures.Continue
Trice Medical has received an additional $6.5 million in Series B financing, raising the total round to $18.1 million. HealthQuest Capital was the lead investor of the extension. Other backers included Safeguard Scientifics Inc and BioStar Ventures. Based in King of Prussia, Pennsylvania, Trice Medical is a provider of private diagnostics solutions focused on micro-invasive technologies.Continue
Minnesota-based medical device firm Conventus Orthopaedics has received $24 million in funding. The investors included Deerfield Management Company, Ally Bridge Group, Sightline Partners, Spray Fund, Blue Stem Capital, BioStar Ventures and Blue Sky Fund.Continue
VytronUS, a Sunnyvale, Calif.-based medical device firm, has raised $31.6 million in Series B financing. The investors included Apple Tree Partners, BioStar Ventures, Windham Venture Partners and New Enterprise Associates. In addition to the funding, David McIntyre and Sami Hamade of Apple Tree Partners and Hank Kucheman of BioStar Ventures have been named to the VytronUS board of directors.Continue
Trice Medical has received $11.6 million in Series B funding. Safeguard Scientifics led the round with participation from other investors that included BioStar Ventures. In addition to the funding, executive chair Jeffrey F. O’Donnell Sr. will transition to chairman and CEO. Based in King of Prussia, Penn., Trice Medical is a private diagnostics firm focused on micro invasive technologies.Continue
Domain Surgical has received $35 million in financing. The investors include OrbiMed and BioStar Ventures. Leerink Partners was the placement agent for the transaction. Headquartered in Salt Lake City, Domain Surgical is a producer of advanced thermal surgical technology.Continue
Teleflex, a provider of medical devices for critical care and surgery, has acquired Hotspur Technologies. Hotspur Technologies, based in Mountain View, CA, is a developer of innovative, catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels. Prior to the acquisition by Teleflex, Hotspur was privately held. Investors included ONSET Ventures, Finistere Ventures, […]Continue
Venture-backed BioSig Technologies, a medical device company developing clinical solutions for diagnoses and treatments of abnormal heart rhythms, has hired Jeffrey O’Donnell to the company’s board of directors. Currently, O’Donnell is a venture partner of Biostar Ventures, a venture capital firm investing in early stage medical device companies. Previously he was the CEO of Embrella […]Continue
CV Ingenuity, the privately-held medical device company, has raised $16 million led by VC New Enterprise Associates. Existing investors BioStar Ventures, Synergy Ventures and Western Technology also participated in the round.Continue
peHUB readers tell me they’d like to learn more about potential funding opportunities that might not yet be in their deal pipeline. With that in mind, we’ve put together a list of companies that are still in the market, based on SEC filings and our own reporting.
Know about other companies that should be on this list? Let me know at [email protected] And if you’re on this list and have raised money since your last SEC filing, please shoot me an email so I can update readers.
Below this list, you’ll find another section about companies that have concluded their fundraising efforts…Continue
BioStar Ventures, a firm focused on early-stage medical device startups, is looking to raise $75 million for its second fund, according to VentureWire. The Michigan-based firm has already secured $30 million, and expects to hold a final close next year. www.biostarventures.comContinue